CIK 0001574094 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271448452
- Phone
- 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $0.90 ($4,507)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $0.85 ($4,262)
- 4 Open-market buy Chief Medical Officer bought 12,000 shares at $0.85 ($10,200)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $0.96 ($9,600)
- 4 Open-market buy Chief Medical Officer bought 22,000 shares at $0.80 ($17,600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $0.93 ($9,297)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 21,000 shares at $1.40 ($29,400)
- 4 Gift Chief Medical Officer gave 400,000 shares (gift)
- 4 Option exercise Director acquired 20,480 shares (option exercise)
- 4 Open-market buy Chief Medical Officer bought 15,000 shares at $0.90 ($13,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 6 · 111 filings